返回
Assertio Holdings Inc（ASRT）價格
ASRT 股價走勢圖
ASRT 收益
Assertio Holdings Inc
$11.48
3.14%
$0.34
收盤價：Jan 16, 16:00:00 GMT-5
$11.56
0.69%
$0.08
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$11.13
開盤價
$11.13
當日範圍
$10.7 - $11.62
52週區間
$7.65 - $15.15
交易量
116.0K
平均成交量
44.5K
每股盈餘 (TTM)
-0.31
股息收益率
--
市值
$1.1B
什麼是 ASRT？
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The company is headquartered in Lake Forest, Illinois and currently employs 58 full-time employees. The firm has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.